IBM(IBM)
IBM
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $71.49B | $74.64B | $78.92B | $82.18B | $82.90B |
| Low | $71.21B | $73.95B | $78.92B | $81.12B | $81.83B |
| High | $72.20B | $75.42B | $78.93B | $83.21B | $83.93B |
| EBITDA Avg | $14.62B | $15.26B | $16.14B | $16.80B | $16.95B |
| Low | $14.56B | $15.12B | $16.14B | $16.59B | $16.73B |
| High | $14.76B | $15.42B | $16.14B | $17.01B | $17.16B |
| EBIT Avg | $8.74B | $9.13B | $9.65B | $10.05B | $10.14B |
| Low | $8.71B | $9.04B | $9.65B | $9.92B | $10.01B |
| High | $8.83B | $9.22B | $9.65B | $10.17B | $10.26B |
| Net Income Avg | $11.72B | $12.60B | $14.10B | $13.63B | $12.08B |
| Low | $11.51B | $11.97B | $12.90B | $13.40B | $11.87B |
| High | $11.93B | $13.24B | $15.30B | $13.85B | $12.27B |
| EPS Avg | $12.43 | $13.39 | $14.72 | $14.36 | $12.73 |
| Low | $12.13 | $12.62 | $13.60 | $14.12 | $12.52 |
| High | $12.57 | $13.95 | $16.13 | $14.60 | $12.94 |
| Analysts (Rev / EPS) | 16 / 13 | 16 / 13 | 12 / 5 | 11 / 1 | 6 / 1 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $17.84B | $17.12B | $20.58B | $16.70B | $18.62B | $17.81B | $21.44B | $16.96B |
| Low | $17.74B | $17.01B | $20.35B | $16.52B | $18.42B | $17.61B | $21.21B | $16.77B |
| High | $18.08B | $17.43B | $20.80B | $16.88B | $18.83B | $18.00B | $21.68B | $17.14B |
| EBITDA Avg | $3.65B | $3.50B | $4.21B | $3.41B | $3.81B | $3.64B | $4.38B | $3.47B |
| Low | $3.63B | $3.48B | $4.16B | $3.38B | $3.77B | $3.60B | $4.34B | $3.43B |
| High | $3.70B | $3.56B | $4.25B | $3.45B | $3.85B | $3.68B | $4.43B | $3.50B |
| EBIT Avg | $2.18B | $2.09B | $2.52B | $2.04B | $2.28B | $2.18B | $2.62B | $2.07B |
| Low | $2.17B | $2.08B | $2.49B | $2.02B | $2.25B | $2.15B | $2.59B | $2.05B |
| High | $2.21B | $2.13B | $2.54B | $2.06B | $2.30B | $2.20B | $2.65B | $2.10B |
| Net Income Avg | $2.87B | $2.79B | $4.37B | $1.95B | $3.09B | $3.02B | $4.63B | $2.09B |
| Low | $2.82B | $2.73B | $4.31B | $1.92B | $3.05B | $2.98B | $4.56B | $2.06B |
| High | $2.91B | $2.82B | $4.43B | $1.98B | $3.13B | $3.06B | $4.69B | $2.12B |
| EPS Avg | $3.01 | $2.93 | $4.59 | $2.05 | $3.25 | $3.17 | $4.86 | $2.19 |
| Low | $2.96 | $2.87 | $4.53 | $2.02 | $3.20 | $3.13 | $4.79 | $2.16 |
| High | $3.06 | $2.97 | $4.66 | $2.08 | $3.29 | $3.22 | $4.93 | $2.22 |
| Analysts (Rev / EPS) | 11 / 12 | 10 / 11 | 5 / 4 | 5 / 4 | 5 / 5 | 5 / 8 | 5 / 4 | 4 / 5 |